205 related articles for article (PubMed ID: 9858520)
1. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells.
Maurer M; Echtenacher B; Hültner L; Kollias G; Männel DN; Langley KE; Galli SJ
J Exp Med; 1998 Dec; 188(12):2343-8. PubMed ID: 9858520
[TBL] [Abstract][Full Text] [Related]
2. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice.
Piliponsky AM; Chen CC; Grimbaldeston MA; Burns-Guydish SM; Hardy J; Kalesnikoff J; Contag CH; Tsai M; Galli SJ
Am J Pathol; 2010 Feb; 176(2):926-38. PubMed ID: 20035049
[TBL] [Abstract][Full Text] [Related]
3. Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.
Bone-Larson CL; Hogaboam CM; Steinhauser ML; Oliveira SH; Lukacs NW; Strieter RM; Kunkel SL
Am J Pathol; 2000 Oct; 157(4):1177-86. PubMed ID: 11021822
[TBL] [Abstract][Full Text] [Related]
4. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation.
Gommerman JL; Oh DY; Zhou X; Tedder TF; Maurer M; Galli SJ; Carroll MC
J Immunol; 2000 Dec; 165(12):6915-21. PubMed ID: 11120817
[TBL] [Abstract][Full Text] [Related]
5. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells.
Sawada J; Shimizu S; Tamatani T; Kanegasaki S; Saito H; Tanaka A; Kambe N; Nakahata T; Matsuda H
J Immunol; 2005 Mar; 174(6):3626-32. PubMed ID: 15749900
[TBL] [Abstract][Full Text] [Related]
6. Mast cells and resistance to peritoneal sepsis after burn injury.
Shelley O; Murphy T; Lederer JA; Mannick JA; Rodrick ML
Shock; 2003 Jun; 19(6):513-8. PubMed ID: 12785005
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of mast cells does not enhance the impaired survival of Kit(W)/Kit(W-v) mice in a model of low dose intraperitoneal infection with bioluminescent Salmonella typhimurium.
Chatterjea D; Burns-Guydish SM; Sciuto TE; Dvorak A; Contag CH; Galli SJ
Immunol Lett; 2005 Jun; 99(1):122-9. PubMed ID: 15894120
[TBL] [Abstract][Full Text] [Related]
8. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype.
Tsai M; Shih LS; Newlands GF; Takeishi T; Langley KE; Zsebo KM; Miller HR; Geissler EN; Galli SJ
J Exp Med; 1991 Jul; 174(1):125-31. PubMed ID: 1711559
[TBL] [Abstract][Full Text] [Related]
9. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function.
Wershil BK; Tsai M; Geissler EN; Zsebo KM; Galli SJ
J Exp Med; 1992 Jan; 175(1):245-55. PubMed ID: 1370530
[TBL] [Abstract][Full Text] [Related]
10. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice.
Jippo T; Morii E; Ito A; Kitamura Y
J Exp Med; 2003 Jun; 197(11):1417-25. PubMed ID: 12771178
[TBL] [Abstract][Full Text] [Related]
11. Critical protective role of mast cells in a model of acute septic peritonitis.
Echtenacher B; Männel DN; Hültner L
Nature; 1996 May; 381(6577):75-7. PubMed ID: 8609992
[TBL] [Abstract][Full Text] [Related]
12. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
13. Differential release of mast cell interleukin-6 via c-kit.
Gagari E; Tsai M; Lantz CS; Fox LG; Galli SJ
Blood; 1997 Apr; 89(8):2654-63. PubMed ID: 9108382
[TBL] [Abstract][Full Text] [Related]
14. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
[TBL] [Abstract][Full Text] [Related]
16. MITF and SgIGSF: an essential transcription factor and its target adhesion molecule for development and survival of mast cells.
Kitamura Y
Novartis Found Symp; 2005; 271():4-11; discussion 11-4, 95-9. PubMed ID: 16605125
[TBL] [Abstract][Full Text] [Related]
17. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents.
Taylor AM; Galli SJ; Coleman JW
Immunology; 1995 Nov; 86(3):427-33. PubMed ID: 8550081
[TBL] [Abstract][Full Text] [Related]
18. Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis.
Kanamaru Y; Sumiyoshi K; Ushio H; Ogawa H; Okumura K; Nakao A
J Immunol; 2005 Apr; 174(7):4193-7. PubMed ID: 15778380
[TBL] [Abstract][Full Text] [Related]
19. Impaired mast cell-dependent natural immunity in complement C3-deficient mice.
Prodeus AP; Zhou X; Maurer M; Galli SJ; Carroll MC
Nature; 1997 Nov; 390(6656):172-5. PubMed ID: 9367154
[TBL] [Abstract][Full Text] [Related]
20. Mast cells as sentinels of innate immunity.
Galli SJ; Maurer M; Lantz CS
Curr Opin Immunol; 1999 Feb; 11(1):53-9. PubMed ID: 10047539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
